Intel Other Non-Current Liabilities increased by 10.9% to $10.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.3%, from $8.74B to $10.43B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 21.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.33B | $5.39B | $5.07B | $5.19B | $5.18B | $5.76B | $8.98B | $4.84B | $7.64B | $7.95B | $6.58B | $6.90B | $5.41B | $7.05B | $9.51B | $8.74B | $7.78B | $11.43B | $9.41B | $10.43B |
| QoQ Change | — | +1.1% | -5.9% | +2.4% | -0.3% | +11.2% | +55.9% | -46.1% | +57.9% | +4.0% | -17.2% | +4.9% | -21.5% | +30.3% | +34.9% | -8.0% | -11.1% | +47.0% | -17.7% | +10.9% |
| YoY Change | — | — | — | — | -2.8% | +6.9% | +77.0% | -6.8% | +47.6% | +38.0% | -26.8% | +42.5% | -29.2% | -11.3% | +44.5% | +26.8% | +43.8% | +62.2% | -1.0% | +19.3% |